Company: SHPH
Filing Date: 2025-02-26
Form Type: 10-K
Source: 0001493152-25-008300
Chunk: 435

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-02-26
Form: 10-K
Item: Item 1B
Chunk 435
---
 April 2021, Mr. Vander Hoek served
as Director, Finance and Business Development at Georgetown Lombardi Comprehensive Cancer Center (“LCCC”), where he directed
a new five-year $221.9 million institutional commitment for cancer center research under a new NCI-approved cancer consortium arrangement
and recruited scientists to fulfill strategic objectives with senior leaders to improve cancer research and treatment. From 2007 until
November 2019, Mr. Vander Hoek served as Associate Director, Administration, at Georgetown’s LCCC, where he was responsible for
direct administrative operations for more than 400 faculty and staff in the department of oncology, radiation medicine, pathology and
biostatistics, bioinformatics and biomathematics, including managing $216.9 million in institutional commitments to LCCC from Medstar
Health, John Theurer Cancer Center (“JTCC”), and Georgetown University. and implementing an enterprise-wide clinical trial
management system for Georgetown University and Medstar Health. From 2004 until 2007, Mr. Vander Hoek served as Chief Financial Officer
at Georgetown’s LCCC. During his time at Georgetown, Mr. Vander Hoek negotiated a series of 12 research integration agreements
between LCCC and the JTCC that resulted in the approval of an NCI recognized Consortium in 2019. From 2001 until 2004, Mr. Vander Hoek
served as Vice-Chair, Planning and Administration, at MedStar Georgetown University Hospital, where he was responsible for managing administrative
and financial operations for some 440 staff, physicians, residents and fellows in the departments of Medicine and Neurology. From 1996
until 2001, Mr. Vander Hoek served as Senior Associate Administrator, Finance and Information Systems, for the Department of Medicine,
Georgetown University Medical Center, where he designed and managed the faculty compensation system, while managing the finances and
information systems for the department. His financial management experience in publicly held companies includes Director of Managed Care
Reimbursement for Critical Care America from 1990 to 1993 and Regional Controller for Laboratory Corporation of America (LabCorp) from
1993 to 1996. His responsibilities at both companies included extensive financial management related to mergers, acquisitions, and start-up
operations. Mr. Vander Hoek holds a Master’s in Health Services Administration from The George Washington University and a Bachelor
of Arts in Biology and Psychology from Hope College.

70

Peter
Dritschilo has served as our President and Chief Operating Officer